Vet Pathol Download to Citation Manager
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Funakoshi, Y.
Right arrow Articles by Doi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Funakoshi, Y.
Right arrow Articles by Doi, K.
Vet Pathol 37:177-183 (2000)
© 2000 American College of Veterinary Pathologists

Cellular Proliferative and Telomerase Activity in Canine Mammary Gland Tumors

Y. Funakoshi, H. Nakayama, K. Uetsuka, R. Nishimura, N. Sasaki and K. Doi

Departments of Veterinary Pathology (YF, HN, KU, KD) and Veterinary Surgery (RN, NS), Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan

In canine mammary tumors, we examined the telomerase activity, proliferative activity by proliferative cell nuclear antigen (PCNA) immunohistochemistry, and percentage of apoptotic cells by the deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) method. The relationship between these measures and histopathologic malignancy was also investigated. PCNA index was highest in malignant tumors (adenocarcinoma: 27.0%; malignant mixed tumor: 15.7%), followed by benign tumors (adenoma: 4.4%; benign mixed tumor: 5.3%), hyperplasia (2.1%), and normal mammary gland (0.9%). In adenoma and adenocarcinoma, papillary and solid types showing higher cellularity tended to have higher PCNA indices than did cystic and tubular types. Although the TUNEL index was <1% in all cases, the relationship between this measure and histopathologic diagnosis showed the same tendency as observed in PCNA immunostaining. Telomerase activity was detectable in all adenomas, benign mixed tumors, and adenocarcinomas examined. In contrast, all normal mammary glands, hyperplasias, and malignant mixed tumors were negative for telomerase. Relative telomerase activity (RTA) of adenocarcinoma (56.5) was significantly higher than that of adenoma (27.8) and benign mixed tumor (33.9), and a significant positive correlation (P < 0.001) was noted between RTA and PCNA index. No significant correlations were noted between either PCNA or TUNEL index and clinical features such as metastasis and tumor diameter. PCNA index and telomerase activity may be useful markers for judging malignancy of canine mammary tumors.


Key words: Dog; mammary gland tumor; PCNA; telomerase activity; TUNEL.

Request reprints from Kunio Doi or Hiroyuki Nakayama, Department of Veterinary Pathology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657 (Japan). E-mail: akunio{at}mail.ecc.u-tokyo.ac.jp or anakaya{at}mail.ecc.u-tokyo.ac.jp.




This article has been cited by other articles:


Home page
Vet PatholHome page
L. N. Torres, J. M. Matera, C. H. Vasconcellos, J. L. Avanzo, F. J. Hernandez-Blazquez, and M. L. Z. Dagli
Expression of Connexins 26 and 43 in Canine Hyperplastic and Neoplastic Mammary Glands
Vet. Pathol., September 1, 2005; 42(5): 633 - 641.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
D. J. Argyle and L. Nasir
Telomerase: A Potential Diagnostic and Therapeutic Tool in Canine Oncology
Vet. Pathol., January 1, 2003; 40(1): 1 - 7.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Veterinary Pathologists.